Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oral Tablets
Pharma
US re-ups Merck oral COVID med deal for 1.4M courses
The U.S. bought 1.4M more courses of COVID-19 oral antiviral molnupiravir, bringing Merck's supply of the drug to the U.S. to 3.1M and a $2.2B haul.
Kevin Dunleavy
Nov 9, 2021 8:34am
After years of buzz, continuous manufacturing is gaining steam
Jun 1, 2021 8:40am
Novo to beef up Rybelsus production capacity in Denmark
Feb 25, 2021 9:41am
FDA smacks Allay Pharma's Florida plant with warning letter
Feb 10, 2021 12:30pm
AvKARE bottles mix antidepressant and ED med, triggering recall
Dec 14, 2020 10:10am
